News | February 14, 2022
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
